Historical data of the Intervest share
Number of shares | 31.12.2022 | 31.12.2021 | 31.12.2020 | 31.12.2019 | 31.12.2018 | |
---|---|---|---|---|---|---|
Number of shares at the end of the period | 29.235.067 | 26.300.908 | 25.500.672 | 24.657.003 | 24.288.997 | |
Number of shares entitled to dividend | 29.235.067 | 26.300.908 | 25.500.672 | 24.657.003 | 24.288.997 | |
Free float (%) | 85% | 85% | 80% | 85% | 85% |
Stock market data | 31.12.2022 | 31.12.2021 | 31.12.2020 | 31.12.2019 | 31.12.2018 | |
---|---|---|---|---|---|---|
Highest closing share price (€) | 29,60 | 28,35 | 29,15 | 28,40 | 22,96 | |
Lowest closing share price (€) | 18,54 | 20,10 | 16,90 | 20,60 | 19,74 | |
Share price on closing date (€) | 19,24 | 28,20 | 22,55 | 25,60 | 20,60 | |
Premium with regard to fair value (%) | -18,9% | 19% | 5% | 20% | 5% | |
Average share price (€) | 24,88 | 23,92 | 23,03 | 24,93 | 21,69 | |
Number of shares traded per year | 8.136.081 | 7.646.263 | 7.476.507 | 6.960.147 | 4.595.938 | |
Average number of shares traded per day | 31.658 | 29.637 | 29.091 | 27.295 | 18.094 | |
Speed of share turnover (%) | 27,8% | 29,1% | 29,3% | 28,2% | 19,0% |
Key figures per share | 31.12.2022 | 31.12.2021 | 31.12.2020 | 31.12.2019 | 31.12.2018 | 31.12.2017 | |
---|---|---|---|---|---|---|---|
Net value (fair value)*(€) | 23,72 | 23,67 | 21,46 | 21,25 | 19,62 | 19,52 | |
Net asset value EPRA (€) | 23,51 | 24,88 | 22,42 | 21,79 | 19,88 | 19,62 | |
Market capitalisation (million €) | 562 | 576 | 575 | 631 | 500 | 414 | |
Pay-out ratio (%) | 90% | 88% | 95% | 80% | 86% | 91% | |
Gross dividend (€) | 1,53** | 1,53** | 1,53 | 1,53 | 1,40 | 1,40 | |
Percentage withholding tax (%) | 30% | 30% | 30% | 30% | 30% | 30% | |
Net dividend (€) | 1,0710 | 1,0710 | 1,0710 | 1,0710 | 0,9800 | 0,9800 | |
Gross dividend yield (%) | 8,0% | 5,4% | 6,8% | 6,0% | 6,8% | 6,2% | |
Net dividend yield (%) | 5,6% | 5,6% | 4,7% | 4,2% | 4,8% | 4,3% |
* The net value (fair value) corresponds to the net value as defined in article 2, 23° of the RREC Act.
**Subject to approval by the annual general meeting to be held in 2023.